UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
MSD Korea’s trade union refuses to use controversial monitoring program
The labor union of MSD Korea went up and arms about the company’s enhanced ...
by Kim Yun-mi
|
2020-06-11 14:31
라인
MSD Korea’s privacy breach controversy resurfaces
MSD Korea’s “Self-Assurance Program (SAP),” recording conversations of doct...
by Kim Yun-mi
|
2020-06-09 11:26
라인
Drug sales reps move briskly amid worries over Covid-19 resurge
Visits by pharmaceutical sales representatives to doctors have begun to reb...
by Kim Yun-mi
|
2020-06-08 15:52
라인
Rinvoq joins competition among JAK inhibitors
AbbVie Korea has obtained approval for rheumatoid arthritis treatment Rinvo...
by Kim Yun-mi
|
2020-06-05 16:16
라인
‘Alecensa beat crizotinib as treatment of ALK-positive NSCLC’
Over the past decade, the first-generation tyrosine kinase inhibitor (TKI) ...
by Kim Yun-mi
|
2020-06-05 14:53
라인
Seoul OKs special import of remdesivir as Covid-19 treatment
The Ministry of Food and Drug Safety said it has granted emergency approval...
by Kim Yun-mi
|
2020-06-03 16:05
라인
‘KOEDC to broaden drug accessibility for patients with rare diseases’
“As the head of Korea Orphan and Essential Drug Center putting patients fir...
by Kim Yun-mi
|
2020-06-03 12:37
라인
‘Keytruda doubled survival in advanced colon cancer compared to chemo’
MSD’s Keytruda (ingredient: pembrolizumab) extended the progression-free su...
by Kim Yun-mi
|
2020-06-02 11:27
라인
Psychiatric nurse prevents patient violence with quick judgment
The police arrested a woman in her 40s who wielded a knife against a nurse ...
by Kim Yun-mi
|
2020-05-29 17:00
라인
Heathcare experts shun online meetings: survey
The spread of the new coronavirus infections generated a rising trend of no...
by Kim Yun-mi
|
2020-05-29 16:55
라인
Kisqali offers survival benefit to breast cancer patients with visceral metastases
Novartis’ Kisqali, a treatment for metastatic breast cancer, showed a consi...
by Kim Yun-mi
|
2020-05-29 10:58
라인
[News Focus] Remdesivir alone not enough to kill Covid-19
Remdesivir has emerged as the drug to treat the new coronavirus infection, ...
by Kim Yun-mi
|
2020-05-27 14:20
라인
Regulator suspends sales of 31 diabetes drugs citing possible carcinogen
The government said it ordered pharmaceutical firms to temporarily suspend ...
by Kim Yun-mi
|
2020-05-26 14:50
라인
Korean pharma’s Q1 performance not affected by Covid-19
Despite the global spread of the new coronavirus, the local pharmaceutical ...
by Kim Yun-mi
|
2020-05-22 17:29
라인
‘No reckless interpretations of Moderna’s Covid-19 vaccine results’
An infectious disease expert cautioned against the hasty interpretation of ...
by Kim Yun-mi
|
2020-05-22 15:27
라인
Cancer patients demand Ono, BMS, MSD share immunotherapy cost
Immunotherapies Optivo, marketed by Ono Pharma Korea and BMS Korea, and Key...
by Kim Yun-mi
|
2020-05-15 15:56
라인
Regulator detects illegal substances in directly purchased health food
The government said it has detected unauthorized substances in seven foreig...
by Kim Yun-mi
|
2020-05-14 16:05
라인
‘Lynparza extended survival of ovarian cancer patients’
AstraZeneca said Lynparza (ingredient: olaparib) has become the first poly ...
by Kim Yun-mi
|
2020-05-14 15:14
라인
AZ, Takeda use different strategies on ovarian cancer
AstraZeneca’s Lynparza (ingredient: olaparib) and Takeda’s Zejula (nirapari...
by Kim Yun-mi
|
2020-05-13 12:34
라인
Metformin sparks heated discussions among diabetes experts
At an online conference by the Korean Diabetes Association amid the Covid-1...
by Kim Yun-mi
|
2020-05-12 15:21
-
1
2
3
4
5
6
7
8
9
10
다음
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top